Trading Signals: BCRX Stock Price Prediction and Forecast (Tue. Sep. 2, 2003 - Wed. Sep. 27, 2023)(BioCryst Pharmaceuticals, Inc.)
| BCRX latest price $12.6550 (2.22%) ($12.6550 - $12.6550) on Fri. Sep. 30, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.01% (three month average) | RSI | 40 | Latest Price | $12.6550(2.22%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BCRX advances 0.6% a day on average for past five trading days. | Weekly Trend | BCRX declines -2.8% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support BCRX advance at 0% a week (0% probability) URA(31%) VT(31%) VUG(31%) XLK(31%) BLOK(29%) | Factors Impacting BCRX price | BCRX will decline at least -2.005% in a week (0% probabilities). VIXM(-13%) UUP(-12%) SMH(-12%) VXX(-3%) TLT(-1%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.005% (StdDev 4.01%) | Hourly BBV | 0.1 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $4.75(-62.47%) | Resistance Level | $13.1 | 5 Day Moving Average | $12.52(1.08%) | 10 Day Moving Average | $12.75(-0.75%) | 20 Day Moving Average | $13.1(-3.4%) | To recent high | -14.6% | To recent low | 20.4% | Market Cap | $2.233b | | | | BioCryst Pharmaceuticals, Inc. designs and develops novel, oral and small-molecule medicines. Its drug candidates include Berotralstat, BCX9930, BCX9250, RAPIVAB, ALPIVAB, RAPIACTA, PERAMIFLU, Galidesivir and Mundesine. The company was founded in 1986 and is headquartered in Durham, NC. |